EP4406601A3
Exon skipping oligomer conjugates for muscular dystrophy
Abstract
Antisense oligomer conjugates complementary to a selected target site in the human dystrophin gene to induce exon 45 skipping are described.
Term
Projected expiry 14 December 2037.
- Priority
- Filed
- Published
- Today
- Projected expiry
Every citation, both ways
| Document | Relation | Office | Cited during |
|---|---|---|---|
| WO2010048586A1 | Cites | World Intellectual Property Organization (WIPO) | Search report |
| WO2012150960A1 | Cites | World Intellectual Property Organization (WIPO) | Search report |
| WO2014153220A2 | Cites | World Intellectual Property Organization (WIPO) | Search report |
| WO2017062835A2 | Cites | World Intellectual Property Organization (WIPO) | Search report |
74 members in 33 offices
Priority claims11
| Document | Office | Kind | Date |
|---|---|---|---|
| 201662436199 | United States of America | P | |
| 201662436199P | United States of America | – | |
| 201762443481 | United States of America | P | |
| 201762443481P | United States of America | – | |
| 201762479177 | United States of America | P | |
| 201762479177P | United States of America | – | |
| 201762562119 | United States of America | P | |
| 201762562119P | United States of America | – | |
| 17832405 | European Patent Office (EPO) | A | |
| 2017066351 | United States of America | W | |
| 22180767 | European Patent Office (EPO) | A |
Members74
| Document | Office | Kind | |
|---|---|---|---|
| CA3046801A1 | Canada | A1 | |
| WO2018118627A1 | World Intellectual Property Organization (WIPO) | A1 | |
| TW201840339A | Taiwan Province of China | A | |
| AR110537A1 | Argentina | A1 | |
| AU2017382741A1 | Australia | A1 | |
| MX2019006989A | Mexico | A | |
| KR20190099001A | Republic of Korea | A | |
| IL267245A | Israel | A | |
| CO2019007398A2 | Colombia | A2 | |
| CN110337308A | China | A | |
| EP3554554A1 | European Patent Office (EPO) | A1 | |
| MA47015A | Morocco | A | |
| MA47015A | Morocco | A | |
| EA201991449A1 | Eurasian Patent Organization (EAPO) | A1 | |
| BR112019012651A2 | Brazil | A2 | |
| JP2020503010A | Japan | A | |
| US2020078465A1 | United States of America | A1 | |
| SG10202100491QA | Singapore | A | |
| US2021077628A2 | United States of America | A2 | |
| SA519402143A | Saudi Arabia | A | |
| SA10146B1 | Saudi Arabia | B1 | |
| SA519402143B1 | Saudi Arabia | B1 | |
| JP2022101695A | Japan | A | |
| US11382981B2 | United States of America | B2 | |
| JP7125940B2 | Japan | B2 | |
| EP3554554B1 | European Patent Office (EPO) | B1 | |
| TWI780095B | Taiwan Province of China | B | |
| DK3554554T3 | Denmark | T3 | |
| PT3554554T | Portugal | T | |
| LT3554554T | Lithuania | T | |
| ES2929498T3 | Spain | T3 | |
| MA47015B1 | Morocco | B1 | |
| RS63705B1 | Serbia | B1 | |
| US2022387601A1 | United States of America | A1 | |
| PL3554554T3 | Poland | T3 | |
| ZA201903940B | South Africa | B | |
| HRP20221316T1 | Croatia | T1 | |
| MD3554554T2 | Republic of Moldova | T2 | |
| SMT202200440T1 | San Marino | T1 | |
| EP4122497A1 | European Patent Office (EPO) | A1 | |
| HUE060065T2 | Hungary | T2 | |
| SI3554554T1 | Slovenia | T1 | |
| NZ755422A | New Zealand | A | |
| IL267245B | Israel | B | |
| IL267245B1 | Israel | B1 | |
| CN110337308B | China | B | |
| IL304284A | Israel | A | |
| IL267245B2 | Israel | B2 | |
| CN117298290A | China | A | |
| KR20240006023A | Republic of Korea | A | |
| KR102639633B1 | Republic of Korea | B1 | |
| EP4122497B1 | European Patent Office (EPO) | B1 | |
| FI4122497T3 | Finland | T3 | |
| DK4122497T3 | Denmark | T3 | |
| LT4122497T | Lithuania | T | |
| PT4122497T | Portugal | T | |
| MA65895B1 | Morocco | B1 | |
| RS65583B1 | Serbia | B1 | |
| SMT202400222T1 | San Marino | T1 | |
| EP4406601A2 | European Patent Office (EPO) | A2 | |
| PL4122497T3 | Poland | T3 | |
| JP2024113187A | Japan | A | |
| HUE066576T2 | Hungary | T2 | |
| HRP20240705T1 | Croatia | T1 | |
| SI4122497T1 | Slovenia | T1 | |
| EP4406601A3This record | European Patent Office (EPO) | A3 | |
| MD4122497T2 | Republic of Moldova | T2 | |
| ES2980686T3 | Spain | T3 | |
| MY205600A | Malaysia | A | |
| IL304284B1 | Israel | B1 | |
| AU2017382741B2 | Australia | B2 | |
| IL304284B2 | Israel | B2 | |
| US12377150B2 | United States of America | B2 | |
| JP7728923B2 | Japan | B2 |
12 legal events, as 2 offices reported them to INPADOC
Over the term
Point at a mark for the eventEvents
| Event | Code | Office | |
|---|---|---|---|
| Application deemed to be withdrawnWithdrawn18D | 18D | EP | |
| Information on the status of an ep patent application or granted ep patentGrantedSTATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWNSTAA | STAA | EP | |
| Designated contracting statesAK | AK | EP | |
| Information provided on ipc code assigned before grantRIC1 | RIC1 | EP | |
| Information provided on ipc code assigned before grantRIC1 | RIC1 | EP | |
| Search report despatchedORIGINAL CODE: 0009013PUAL | PUAL | EP | |
| Amendment of ipc main classPREVIOUS MAIN CLASS: A61P0021000000R079 | R079 | DE | |
| Divisional application: reference to earlier applicationAC | AC | EP | |
| Divisional application: reference to earlier applicationAC | AC | EP | |
| Designated contracting statesAK | AK | EP | |
| Public reference made under article 153(3) epc to a published international application that has entered the european phaseORIGINAL CODE: 0009012PUAI | PUAI | EP | |
| Information on the status of an ep patent application or granted ep patentGrantedSTATUS: THE APPLICATION HAS BEEN PUBLISHEDSTAA | STAA | EP |
Numbers
- Publication
- 4406601
- Application
- 24163334
Titles3
- German
- EXON-SKIPPING-OLIGOMERKONJUGATE FÜR MUSKELDYSTROPHIE
- English
- EXON SKIPPING OLIGOMER CONJUGATES FOR MUSCULAR DYSTROPHY
- French
- CONJUGUÉS OLIGOMÈRES DE SAUT D'EXON POUR LA DYSTROPHIE MUSCULAIRE
Classification
- CPC, 9
- C12N15/113
- A61K47/645
- A61K47/549
- A61K31/7088
- A61P21/00
- C12N2310/11
- C12N2320/35
- C12N2310/3513
- C12N2310/3233
- IPC, 2
- A61K47 64
- A61P21 00
Designated states3
- Contracting states, 1
- Türkiye
- Extension states, 1
- Montenegro
- Validation states, 1
- Tunisia